11/14/2024
3:32 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Kura Oncology (Subject)
| Form SC 13G/A | |
06/07/2024
3:30 PM | Collins Helen Louise (Reporting)
Kura Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:30 PM | Hasnain Faheem (Reporting)
Kura Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:30 PM | Kura Oncology (Issuer)
Malley Thomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:30 PM | Kura Oncology (Issuer)
SCHAFER CAROL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:30 PM | Kura Oncology (Issuer)
Parks Diane L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:30 PM | Kura Oncology (Issuer)
Szela Mary T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
06/07/2024
3:30 PM | Kura Oncology (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/24/2024
3:06 PM | Kura Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/20/2024
5:30 PM | Bair Teresa Brophy (Reporting)
Kura Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
3:19 PM | Bair Teresa Brophy (Reporting)
Kura Oncology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/02/2024
3:34 PM | Kura Oncology (Subject)
Paradigm Biocapital Advisors LP (Filed by)
| Form SC 13G | |
05/02/2024
3:15 PM | Kura Oncology (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/12/2024
3:26 PM | Kura Oncology (Filer)
| Form DEF 14A | |
04/12/2024
3:26 PM | Kura Oncology (Filer)
| Form DEFA14A | |
02/14/2024
11:15 PM | Kura Oncology (Filer)
| Form EFFECT | |
02/14/2024
8:39 AM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Kura Oncology (Subject)
| Form SC 13G/A | |
02/13/2024
4:23 PM | Kura Oncology (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
| Form SC 13G/A | |
02/12/2024
4:33 PM | Flynn James E (Filed by)
Kura Oncology (Subject)
| Form SC 13G/A | |
02/09/2024
4:21 PM | Kura Oncology (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
01/31/2024
4:30 PM | DALE STEPHEN (Reporting)
Kura Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
4:30 PM | FORD KATHLEEN (Reporting)
Kura Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
4:30 PM | Bair Teresa Brophy (Reporting)
Kura Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
4:30 PM | DOYLE THOMAS JAMES (Reporting)
Kura Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2024
6:08 AM | Kura Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/24/2024
1:27 PM | BlackRock Inc. (Filed by)
Kura Oncology (Subject)
| Form SC 13G/A | |
01/23/2024
8:12 AM | Kura Oncology (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/04/2024
3:06 PM | DALE STEPHEN (Reporting)
Kura Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:07 PM | Bair Teresa Brophy (Reporting)
Kura Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:07 PM | FORD KATHLEEN (Reporting)
Kura Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:07 PM | Kura Oncology (Issuer)
Powl Brian T. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:08 PM | DOYLE THOMAS JAMES (Reporting)
Kura Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
3:06 PM | Kura Oncology (Issuer)
WILSON TROY EDWARD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/22/2023
8:01 AM | Kura Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
